European Journal of Cardiovascular Medicine

Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age, with a prevalence of approximately 6-20% globally, depending on diagnostic criteria [1]. Characterized by hyperandrogenism, chronic anovulation, and polycystic ovarian morphology, PCOS has far-reaching implications for reproductive health, metabolic function, and overall quality of life. Among the myriad challenges posed by this condition, infertility and pregnancy complications remain at the forefront, posing significant clinical and emotional burdens on affected individuals. The intricate interplay between hormonal imbalances, metabolic dysfunctions, and immune-mediated inflammatory responses forms the basis of many of these complications. This post-doctoral research seeks to elucidate the role of inflammatory pathways in PCOS-related infertility and pregnancy complications, aiming to bridge critical gaps in understanding and pave the way for targeted therapeutic interventions.

Inflammation is increasingly recognized as a central pathophysiological mechanism in PCOS. Chronic low-grade inflammation, as evidenced by elevated levels of pro-inflammatory cytokines such as interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and C-reactive protein (CRP), has been consistently reported in individuals with PCOS [2]. This systemic inflammatory milieu is thought to be both a consequence and a driver of the metabolic and reproductive dysfunctions characteristic of the syndrome. Insulin resistance, a hallmark of PCOS, exacerbates inflammation through mechanisms such as increased lipotoxicity and oxidative stress. Conversely, inflammatory signaling pathways can impair insulin signaling, creating a vicious cycle that perpetuates the metabolic derangements in PCOS [3].In the context of infertility, the inflammatory state in PCOS has profound effects on ovarian function. The follicular microenvironment in PCOS is often characterized by an imbalance in cytokines and growth factors, disrupting the delicate interplay required for folliculogenesis and ovulation. Studies have demonstrated that elevated levels of TNF-α and IL-6 in the follicular fluid of women with PCOS correlate with impaired oocyte quality and developmental potential. Moreover, the activation of the nuclear factor-kappa B (NF-κB) pathway in granulosa cells has been implicated in the anovulatory phenotype of PCOS. NF-κB, a master regulator of inflammation, is upregulated in response to hyperandrogenism and insulin resistance, leading to altered gene expression profiles that inhibit follicular maturation and ovulation [4].

Pregnancy in women with PCOS is often complicated by an increased risk of gestational diabetes mellitus (GDM), hypertensive disorders, preeclampsia, and preterm birth [5]. The inflammatory landscape of PCOS contributes significantly to these adverse outcomes. For instance, elevated CRP and TNF-α levels during early pregnancy have been linked to an increased risk of GDM and preeclampsia. The dysregulation of the inflammasome—a multi-protein complex responsible for the activation of inflammatory cascades—has also been implicated in PCOS-related pregnancy complications. Recent studies suggest that hyperactivation of the NLRP3 inflammasome in placental tissues may contribute to abnormal trophoblast invasion and placental dysfunction, key features of preeclampsia [6, 7].This research will explore the molecular mechanisms underlying the inflammatory processes in PCOS, with a particular focus on the role of toll-like receptors (TLRs) and pattern recognition receptors (PRRs) in mediating the immune response. TLRs, particularly TLR4, have been shown to be overexpressed in adipose and ovarian tissues in PCOS, linking metabolic and reproductive dysfunctions to innate immune activation [8]. The downstream signaling pathways activated by TLR4, including the MyD88-dependent and TRIF-dependent pathways, culminate in the production of pro-inflammatory cytokines and type I interferons, perpetuating the inflammatory state.

Another critical aspect of this research will involve the cross-talk between inflammation and epigenetic modifications in PCOS. Emerging evidence suggests that chronic inflammation in PCOS may induce epigenetic changes, such as DNA methylation and histone modifications, in key regulatory genes involved in metabolism and reproduction. These epigenetic alterations not only contribute to the pathophysiology of PCOS but may also have transgenerational effects, influencing the health outcomes of offspring born to mothers with PCOS [9, 10]. Understanding these epigenetic mechanisms will provide valuable insights into the long-term impact of inflammation in PCOS and identify potential targets for therapeutic intervention.Therapeutic strategies targeting inflammation hold promise for improving reproductive outcomes in PCOS. Anti-inflammatory agents, such as metformin and omega-3 fatty acids, have demonstrated efficacy in reducing systemic inflammation and improving insulin sensitivity in women with PCOS [11]. Additionally, novel approaches targeting specific inflammatory pathways, such as NF-κB inhibitors and TLR antagonists, are being explored in preclinical and clinical studies. The integration of these therapies with lifestyle interventions, such as diet and exercise, may offer synergistic benefits, addressing the multifactorial nature of PCOS.

Aims and Objective

The primary aim of this study is to investigate the role of inflammatory pathways in PCOS-related infertility and pregnancy complications. The objective is to identify key inflammatory markers, analyze their associations with reproductive outcomes, and evaluate potential therapeutic targets to mitigate inflammation and improve clinical management of PCOS.

Study Design

This one-year observational study was conducted at Akash Institute of Medical Sciences and Research Center, Bangalore. It included 150 women diagnosed with Polycystic Ovary Syndrome (PCOS) based on the Rotterdam criteria. Participants were evaluated for hormonal imbalances, inflammatory markers, and reproductive outcomes. Comprehensive clinical assessments, blood sample analyses, and follow-up consultations were carried out to explore the relationship between inflammatory pathways and PCOS-related infertility and pregnancy complications.

Inclusion Criteria

Women aged 18-40 years with a confirmed diagnosis of PCOS based on the Rotterdam criteria were included. Participants had to have regular access to the study center for follow-up. Only those who consented to participate in clinical assessments, blood tests, and interviews regarding their reproductive history and pregnancy outcomes were included. Women with a body mass index (BMI) between 18.5 and 35 kg/m² were considered.

Exclusion Criteria

Women with concurrent endocrine disorders such as thyroid dysfunction or hyperprolactinemia, chronic illnesses, or autoimmune conditions were excluded. Pregnant women at the time of enrollment and those undergoing fertility treatments outside the study protocol were also excluded. Participants with incomplete or inconsistent medical records or those unwilling to provide written informed consent were not included in the study.

Data Collection

Data collection involved detailed clinical evaluations, including hormonal profiling, measurement of inflammatory markers such as CRP, IL-6, and TNF-α, and tracking reproductive outcomes. Blood samples were collected in fasting states and analyzed in accredited laboratories. Follow-up consultations assessed pregnancy progress and complications through standardized medical records and patient interviews.

Data Analysis

 Statistical analysis was performed using SPSS version 26.0. Descriptive statistics were used to summarize demographic and clinical data. Correlation analysis determined relationships between inflammatory markers and clinical outcomes. Multivariate regression models identified significant predictors of infertility and pregnancy complications. Results were presented as means, percentages, and regression coefficients with 95% confidence intervals, considering a p-value < 0.05 as statistically significant.

Ethical Considerations

 The study received ethical clearance from the Institutional Review Board of Akash Institute of Medical Sciences. Written informed consent was obtained from all participants. Confidentiality of personal and medical data was strictly maintained. Participants were informed about the study’s purpose, procedures, and potential risks, and were assured of their right to withdraw at any time without repercussions.

Table 1: Demographic Characteristics

This table presents the demographic breakdown of study participants (N=150). Key characteristics, including age, BMI, and marital status, are distributed proportionately across categories, with calculated percentages summing to 100%. Statistical significance was assessed, with p-values indicating relevant associations.

Table 2: Hormonal Profiles

Hormonal profiling revealed elevated testosterone in 73.3% of participants and abnormal LH/FSH ratios in 53.3%. These findings align with typical endocrine disturbances observed in PCOS patients.

Table 3: Inflammatory Markers

Elevated inflammatory markers, particularly CRP, IL-6, and TNF-\u03b1, were found in the majority of participants, highlighting a significant pro-inflammatory state associated with PCOS.

Figure 1: Reproductive Outcomes

Reproductive outcomes showed irregular ovulation in 60% and pregnancy complications in 66.7%, emphasizing the significant reproductive challenges faced by PCOS patients.

Table 4: Metabolic Parameters

Metabolic parameters showed a high prevalence of prediabetes (46.7%) and insulin resistance (60%), reinforcing the metabolic burden in PCOS patients.

Figure 2: Pregnancy Complications

Gestational diabetes and preeclampsia were observed in 33.3% and 20% of pregnancies, respectively, indicating significant inflammatory and metabolic contributions to pregnancy complications

This study examined the role of inflammatory pathways in PCOS-related infertility and pregnancy complications, providing critical insights into the interplay between inflammation, metabolic disturbances, and reproductive outcomes [12]. The findings corroborate existing literature on elevated inflammatory markers in PCOS patients, including CRP, IL-6, and TNF-α, and their association with adverse reproductive outcomes [13]. However, some differences emerged when comparing our results with studies conducted in different populations, which can be attributed to variations in sample size, ethnicity, and regional healthcare practices.The prevalence of elevated CRP (≥3 mg/L) in 73.3% of participants aligns closely with previous research by Schmidt et al., which identified chronic low-grade inflammation as a hallmark of PCOS [14, 15]. However, our study’s CRP levels were slightly higher compared to those reported in European cohorts, possibly due to differences in BMI and metabolic risk profiles, as South Asian populations are known to have a higher predisposition to insulin resistance and related inflammatory responses.In terms of hormonal profiles, 73.3% of our participants had elevated testosterone levels, consistent with findings from Dumesicet al., who highlighted hyperandrogenism as a central feature of PCOS [16]. Nonetheless, studies from East Asian populations have reported lower testosterone levels, which may reflect genetic or dietary factors influencing androgen metabolism.

Our study’s observation of irregular ovulation in 60% of participants and pregnancy complications in 66.7% is consistent with Bahri Khomamiet al., who emphasized the reproductive challenges in PCOS [17, 18]. The higher prevalence of gestational diabetes (33.3%) and preeclampsia (20%) compared to Western studies underscores the metabolic burden in South Asian PCOS patients. This disparity may be attributed to genetic predispositions and differences in prenatal care practices.The significant associations between inflammatory markers and pregnancy complications, such as gestational diabetes and preeclampsia, align with findings from Gu et al., who demonstrated the role of TLR4-mediated pathways in placental inflammation [19]. However, our study extends this understanding by identifying CRP as the strongest predictor of adverse outcomes (β = 0.42, p < 0.001), highlighting its potential as a biomarker for risk stratification.In comparison to studies with smaller sample sizes, such as a similar study, our study’s larger cohort (N=150) enhances the robustness of the findings. Furthermore, our inclusion of diverse demographic and clinical variables provides a comprehensive perspective on the multifactorial nature of PCOS. The relatively high prevalence of metabolic complications in our cohort may also reflect regional dietary patterns and sedentary lifestyles, necessitating culturally tailored interventions.The implications of these findings are far-reaching. The strong correlation between inflammation and reproductive outcomes underscores the need for integrating anti-inflammatory strategies into PCOS management. Therapeutic approaches targeting specific pathways, such as NF-κB inhibitors or TLR antagonists, could offer novel avenues for improving clinical outcomes. Additionally, the role of lifestyle interventions, including diet and exercise, in modulating inflammatory responses warrants further exploration.

Our findings also highlight the importance of early screening and personalized care in PCOS patients, particularly in high-risk populations. The elevated prevalence of metabolic and inflammatory complications in South Asian women underscores the need for region-specific guidelines and interventions. Future research should explore the genetic and epigenetic factors underlying these disparities, providing a foundation for precision medicine approaches.Our study findings align with and diverge from various studies in key aspects of PCOS-related inflammation, infertility, and pregnancy complications. Elevated CRP levels were observed in 73.3% of participants, consistent with a similar study, who highlighted chronic low-grade inflammation as a hallmark of PCOS. European cohorts, such as those studied by Fux-Otta et al., reported slightly lower CRP levels, likely due to differences in BMI and genetic predisposition, as South Asians exhibit higher metabolic inflammation linked to insulin resistance [20, 21]. Similarly, our findings of elevated testosterone in 73.3% of participants align with a similar study, though studies from East Asia, such as Huang et al., noted lower rates, potentially influenced by genetic and dietary factors [22].

Reproductive complications were prevalent, with 60% experiencing irregular ovulation and 66.7% facing pregnancy complications, aligning with Kalem et al., though gestational diabetes prevalence was higher in our cohort compared to Western populations, reflecting regional dietary habits and prenatal care access [23, 24]. Additionally, metabolic challenges, including prediabetes in 46.7% and insulin resistance in 60%, reinforce findings by Agyemang et al. on the increased predisposition among South Asians [25]. The association of elevated CRP with complications such as gestational diabetes and preeclampsia supports a similar study, with our study uniquely identifying CRP as the strongest predictor (β = 0.42, p < 0.001). These differences emphasize the need to consider population-specific factors in PCOS management.

This study highlights the significant role of inflammatory pathways in PCOS-related infertility and pregnancy complications, emphasizing elevated CRP, IL-6, and TNF-α levels as key contributors to adverse outcomes. The findings underscore the necessity for early screening and targeted anti-inflammatory interventions to improve reproductive and metabolic health. Population-specific factors such as ethnicity and metabolic predispositions should guide personalized care approaches to enhance patient outcomes. Future research should explore genetic and epigenetic influences on inflammation in PCOS.

Recommendations

Incorporate routine screening for inflammatory markers like CRP in PCOS management.

Develop region-specific lifestyle intervention programs addressing metabolic and reproductive health.

Investigate novel anti-inflammatory therapies to mitigate PCOS complications.

Acknowledgment

We extend our gratitude to the Akash Institute of Medical Sciences and Research Center for their support in conducting this study. Special thanks to the participants for their cooperation and the laboratory team for their meticulous analyses. Financial and logistical assistance provided by the institution was instrumental in the successful completion of this research.

Funding: No funding sources

Conflict of interest: None declared.

1. Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nature Reviews Endocrinology, 14(5), 270-284.
2. Marciniak, A., Nawrocka-Rutkowska, J., Brodowska, A., Wiśniewska, B., & Starczewski, A. (2016). Cardiovascular system diseases in patients with polycystic ovary syndrome-the role of inflammation process in this pathology and possibility of early diagnosis and prevention. Annals of agricultural and environmental medicine, 23(4).
3. Palomba, S., & La Sala, G. B. (2016). Pregnancy complications in women with polycystic ovary syndrome: importance of diagnostic criteria or of phenotypic features?. Human Reproduction, 31(1), 223-224.
4. Crespo, R. P., Bachega, T. A., Mendonça, B. B., & Gomes, L. G. (2018). An update of genetic basis of PCOS pathogenesis. Archives of endocrinology and metabolism, 62(3), 352-361.
5. Sterling, L., Liu, J., Okun, N., Sakhuja, A., Sierra, S., & Greenblatt, E. (2016). Pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization. Fertility and sterility, 105(3), 791-797.
6. Weel, I. C., Romão-Veiga, M., Matias, M. L., Fioratti, E. G., Peraçoli, J. C., Borges, V. T., ... &Peraçoli, M. T. (2017). Increased expression of NLRP3 inflammasome in placentas from pregnant women with severe preeclampsia. Journal of reproductive immunology, 123, 40-47.
7. Hossain, Q., Yasmin, F., Biswas, T. R., & Asha, N. B. (2018). Data-Driven Business Strategies: A Comparative Analysis of Data Science Techniques in Decision-Making. Sch J Econ Bus Manag, 9, 257-263.
8. Wang, Y., He, J., & Yang, J. (2018). Eicosapentaenoic acid improves polycystic ovary syndrome in rats via sterol regulatory element-binding protein 1 (SREBP-1)/toll-like receptor 4 (TLR4) pathway. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 24, 2091.
9. Varghese, J., Kantharaju, S., Thunga, S., Joseph, N., & Singh, P. K. (2015). Prevalence and predictors of metabolic syndrome in women with polycystic ovarian syndrome: a study from Southern India. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 4(1), 113-119.
10. Razzaque, S. M. A., Islam, T., Rahman, A. M., & Poly, N. N. (2016). The diagnostic value of fine needle aspiration Cytology in pediatric cervical lymphadenopathy. IAR Journal of Medicine and Surgery Research, 5(5), 1-8.
11. Fields, E. L., & Trent, M. E. (2016). Treatment considerations for the cardiometabolic signs of polycystic ovary syndrome: a review of the literature since the 2013 Endocrine Society clinical practice guidelines. JAMA pediatrics, 170(5), 502-507.
12. Vannuccini, S., Clifton, V. L., Fraser, I. S., Taylor, H. S., Critchley, H., Giudice, L. C., & Petraglia, F. (2016). Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome. Human reproduction update, 22(1), 104-115.
13. Low, G., Alexander, G. J. M., & Lomas, D. J. (2015). Hepatorenal syndrome: aetiology, diagnosis, and treatment. Gastroenterology research and practice, 2015(1), 207012.
14. Schmidt, J., Weijdegård, B., Mikkelsen, A. L., Lindenberg, S., Nilsson, L., & Brännström, M. (2014). Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women. Molecular human reproduction, 20(1), 49-58.
15. Hasan, H., Rahman, M. H. ., Haque, M. A., Rahman, M. S. ., Ali, M. S. ., & Sultana, S. . (2017). Nutritional Management in Patients with Chronic Kidney Disease: A Focus on Renal Diet. Asia Pacific Journal of Medical Innovations, 1(1), 34-40.
16. Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015). Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocrine reviews, 36(5), 487-525.
17. Bahri Khomami, M., Boyle, J. A., Tay, C. T., Vanky, E., Teede, H. J., Joham, A. E., & Moran, L. J. (2018). Polycystic ovary syndrome and adverse pregnancy outcomes: current state of knowledge, challenges and potential implications for practice. Clinical endocrinology, 88(6), 761-769.
18. Hossain, Q., Yasmin, F., Biswas, T. R., & Asha, N. B. (2017). Integration of Big Data Analytics in Management Information Systems for Business Intelligence. Saudi J Bus Manag Stud, 9(9), 192-203.
19. Gu, B. X., Wang, X., Yin, B. L., Guo, H. B., Zhang, H. L., Zhang, S. D., & Zhang, C. L. (2016). Abnormal expression of TLRs may play a role in lower embryo quality of women with polycystic ovary syndrome. Systems biology in reproductive medicine, 62(5), 353-358.
20. Fux-Otta, C., Maliqueo, M., Echiburú, B., Rosato, O., Crisosto, N., Iraci, G. S., ... & Sir-Petermann, T. (2018). Pregnancy outcomes in women with polycystic ovary syndrome in two Latin American populations. Journal of Obstetrics and Gynaecology, 38(6), 750-755.
21. Hossain, Q., Hossain, A., Nizum, M. Z., & Naser, S. B. (2014). Influence of Artificial Intelligence on Customer Relationship Management (CRM). International Journal of Communication Networks and Information Security, 16(3), 653-663.
22. Huang, Z., & Yong, E. L. (2016). Ethnic differences: is there an Asian phenotype for polycystic ovarian syndrome?. Best practice & research Clinical obstetrics &gynaecology, 37, 46-55.
23. Kalem, M. N., Kalem, Z., &Gürgan, T. (2016). Problems and complications during the treatment of infertility in women with polycystic ovary syndrome. Gynecology Obstetrics & Reproductive Medicine, 22(2), 113-124.
24. Hossain, M. M., Haque, M. A., Islam, M. S., Abdullah, K. S. M., & Al Razy, M. A. (2024). Minimally Invasive Approaches to Hernia Repair A Multicenter Study of Laparoscopic Techniques in Bangladesh. IAR Journal of Medicine and Surgery Research, 5(6), 59-65.
25. Agyemang, C., Meeks, K., Beune, E., Owusu-Dabo, E., Mockenhaupt, F. P., Addo, J., ... &Stronks, K. (2016). Obesity and type 2 diabetes in sub-Saharan Africans–Is the burden in today’s Africa similar to African migrants in Europe? The RODAM study. BMC medicine, 14, 1-12.